BioNxt Solutions Inc. (CSE:BNXT)
0.5700
-0.0300 (-5.00%)
At close: Feb 9, 2026
BioNxt Solutions Revenue
BioNxt Solutions had revenue of 11.26K CAD in the quarter ending September 30, 2025, a decrease of -34.17%. This brings the company's revenue in the last twelve months to 15.82K, down -62.34% year-over-year. In the year 2024, BioNxt Solutions had annual revenue of 26.99K, down -92.75%.
Revenue (ttm)
15.82K
Revenue Growth
-62.34%
P/S Ratio
4,428.83
Revenue / Employee
n/a
Employees
20
Market Cap
70.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.99K | -345.26K | -92.75% |
| Dec 31, 2023 | 372.25K | 74.81K | 25.15% |
| Dec 31, 2022 | 297.44K | 10.94K | 3.82% |
| Dec 31, 2021 | 286.50K | -59.16K | -17.11% |
| Dec 31, 2020 | 345.65K | 137.54K | 66.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Planet 13 Holdings | 151.05M |
| Medexus Pharmaceuticals | 145.00M |
| Decibel Cannabis Company | 109.31M |
| HLS Therapeutics | 77.79M |
| Charlotte's Web Holdings | 68.58M |
| Vext Science | 66.63M |
| C21 Investments | 46.02M |
| Leef Brands | 45.21M |